$170.17 +1.69 (%) Amgen Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Meet 5 Big Tech Stocks Expected To See Profits Surge

    IBD | Dec. 16, 2014 | 19:46PM EST
  2. Amgen Just Crashed 50% In Premarket, Here's How It Looked

    Benzinga | Dec. 16, 2014 | 09:55AM EST
  3. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus | Dec. 15, 2014 | 16:57PM EST
  4. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD | Dec. 13, 2014 | 08:02AM EST
  5. How Can Drugmakers Handle New Pricing Pressures?

    IBD | Dec. 11, 2014 | 17:38PM EST
  6. Gilead Sciences Bucks Trend In Biotech Short Interest

    Benzinga | Dec. 11, 2014 | 12:06PM EST
  7. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  8. New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA For Advanced Melanoma

    Benzinga | Dec. 8, 2014 | 16:21PM EST
  9. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD | Dec. 4, 2014 | 16:47PM EST
  10. Large-Blend Funds Take The Lead For Year-To-Date Total Returns

    Benzinga | Dec. 2, 2014 | 17:52PM EST
  11. A Look At 3 Overbought ETFs

    Benzinga | Dec. 2, 2014 | 17:34PM EST
  12. Big CEOs Are Less Upbeat, But Plan To Hire More

    IBD | Dec. 2, 2014 | 13:28PM EST
  13. Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA ...

    GuruFocus | Dec. 2, 2014 | 11:03AM EST
  14. Meet 5 Top Drug Stocks That Are Bolting Past Market

    IBD | Dec. 2, 2014 | 08:02AM EST
  15. AMGEN

    IBD | Nov. 25, 2014 | 18:47PM EST
  16. #PreMarket Primer: Tuesday, November 25: Violent Protests In Ferguson Following Grand Jury Decision

    Benzinga | Nov. 25, 2014 | 08:16AM EST
  17. Dividend Aristocrats In Focus Part 45: AbbVie

    GuruFocus | Nov. 24, 2014 | 16:13PM EST
  18. Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies Of Rilotumumab In Advanced Gastric Cancer

    Benzinga | Nov. 24, 2014 | 09:16AM EST
  19. #PreMarket Primer: Wednesday, November 19: Burst Of Cold Creates Chaos In New York

    Benzinga | Nov. 19, 2014 | 07:50AM EST
  20. Merck Drug Works: Vytorin Study Proves Successful

    IBD | Nov. 17, 2014 | 13:35PM EST
  21. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  22. Amgen Shares Consolidating Ahead Of More Gains?

    Benzinga | Nov. 13, 2014 | 13:25PM EST
  23. UPDATE: Deutsche Bank Reiterates On Amgen On Potential Of New Drugs

    Benzinga | Nov. 12, 2014 | 09:17AM EST
  24. Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis

    Benzinga | Nov. 11, 2014 | 16:03PM EST
  25. Big Cap 20 Stuffed With Medical Names

    IBD | Nov. 10, 2014 | 19:34PM EST
  26. Markets Mostly Lower As Americans Head To Vote, Oil Continues To Tumble

    Benzinga | Nov. 4, 2014 | 16:30PM EST
  27. AbbVie Beats Q3 Earnings Estimates, Raises Guidance

    IBD | Oct. 31, 2014 | 14:25PM EST
  28. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  29. Stocks Trim Losses After Fed Report; Solarwinds Soars

    IBD | Oct. 29, 2014 | 16:22PM EST
  30. UPDATE: Nomura Upgrades Amgen

    Benzinga | Oct. 29, 2014 | 11:42AM EST
  31. Amgen resists pressure to split

    IBD | Oct. 28, 2014 | 18:43PM EST
  32. Amgen: Stronger Drug Portfolio with Acquisition

    GuruFocus | Oct. 28, 2014 | 15:34PM EST
  33. Amgen Refuses To Split, But Plans Hearten Investors

    IBD | Oct. 28, 2014 | 14:18PM EST
  34. Amgen At All-Time High, Deutsche Bank Ups Price Target

    Benzinga | Oct. 28, 2014 | 13:33PM EST
  35. Stocks Extend Gains As Alibaba, Tesla Rally

    IBD | Oct. 28, 2014 | 12:04PM EST
  36. Stocks Launch In Climbing Mood; Amgen, Spirit Airlines Climbing

    IBD | Oct. 28, 2014 | 10:36AM EST
  37. Amgen Rallies 3% After Announcing Growth And Capital Plans

    Benzinga | Oct. 28, 2014 | 09:32AM EST
  38. Four Biotechs Lead Health Care Stocks In Big Cap 20

    IBD | Oct. 27, 2014 | 19:00PM EST
  39. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD | Oct. 27, 2014 | 18:56PM EST
  40. Amgen Earnings Clear Views

    IBD | Oct. 27, 2014 | 18:49PM EST
  41. Amgen Beats Q3 Earnings Estimates

    Benzinga | Oct. 27, 2014 | 17:16PM EST
  42. Twitter Off, Amgen, Buffalo Wild Wings Up After Hours

    IBD | Oct. 27, 2014 | 17:04PM EST
  43. Dow, Nasdaq Battle Near Flat Line; Energy Weighs On S&P 500

    IBD | Oct. 27, 2014 | 15:00PM EST
  44. #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations

    Benzinga | Oct. 27, 2014 | 08:19AM EST
  45. Earnings Scheduled For October 27, 2014

    Benzinga | Oct. 27, 2014 | 05:06AM EST
  46. Keep an Eye on These 7 Stocks for October 27, 2014

    Benzinga | Oct. 27, 2014 | 04:21AM EST
  47. Stocks Put End To Four-Week Slide

    IBD | Oct. 24, 2014 | 16:56PM EST
  48. Fast Money Picks For October 23

    Benzinga | Oct. 23, 2014 | 07:00AM EST
  49. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  50. Biotechs Show Fed Chief's Not Much Of A Stock Analyst

    IBD | Oct. 22, 2014 | 17:01PM EST
Trading Center